Regulation of Protein Expression and Function of OCTN2 in Forskolin-Induced Syncytialization in BeWo Cells

Placenta

Volumn 30, Issue 2, 2009, Pages 187-194

  Huang, F D ^a   Kung, F L ^a   Tseng, Y C ^a   Chen, M R ^a   Chan, H S ^a   Lin, C J ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

BeWo cells; Carnitine; NHERF; OCTN2; PDZK; Syncytialization

Indexed keywords

CARNITINE; CHORIONIC GONADOTROPIN BETA SUBUNIT; FORSKOLIN; NHERF1 PROTEIN; NHERF2 PROTEIN; OCTN2 PROTEIN; PDZ PROTEIN; PLACENTA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRUSH BORDER; CANCER CELL CULTURE; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; WESTERN BLOTTING;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FORSKOLIN; GENE EXPRESSION REGULATION; GENE PRODUCTS, ENV; GIANT CELLS; HUMANS; MICROVILLI; ORGANIC CATION TRANSPORT PROTEINS; PHOSPHOPROTEINS; PREGNANCY PROTEINS; SODIUM-HYDROGEN ANTIPORTER; TROPHOBLASTS;

EID: 58249090756     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.11.016     Document Type: Article

References (52)

1. Mi S., Lee X., Li X., Veldman G.M., Finnerty H., Racie L., et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403 (2000) 785-789
2. Blond J.L., Lavillette D., Cheynet V., Bouton O., Oriol G., Fernandes Chapel S., et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 74 (2000) 3321-3329
3. 0 (ASCT2), in human placental choriocarcinoma BeWo cells during syncytialization. Placenta 23 (2002) 536-541
4. Yu C., Shen K., Lin M., Chen P., Lin C., Chang G.-D., et al. GCMa regulates the syncytin-mediated trophoblastic fusion. J Biol Chem 277 (2002) 50062-50068
5. Chang C.W., Chuang H.C., Yu C., Yao T.P., and Chen H. Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. Mol Cell Biol 25 (2005) 8401-8414
6. Knerr I., Schubert S.W., Wich C., Amann K., Aigner T., Vogler T., et al. Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions. FEBS Lett 579 (2005) 3991-3998
7. Ringler G.E., Kao L.C., Miller W.L., and Strauss III J.F. Effects of 8-bromo-cAMP on expression of endocrine functions by cultured human trophoblast cells. Regulation of specific mRNAs. Mol Cell Endocrinol 61 (1989) 13-21
8. Wice B., Menton D., Geuze H., and Schwartz A.L. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp Cell Res 186 (1990) 306-316
9. Keryer G., Alsat E., Taskén K., and Evain-Brion D. Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro. J Cell Sci 111 (1998) 995-1004
10. Shenai J.P., and Borum P.R. Tissue carnitine reserves of newborn infants. Pediatr Res 18 (1984) 679-682
11. Arenas J., Rubio J.C., Martin M.A., and Campos Y. Biological roles of l-carnitine in perinatal metabolism. Early Hum Dev 53 (1998) S43-S50
12. Erasmus M.J., Duncan W.J., and Tyrrell M.J. Congenital complete heart block in an infant with free plasma carnitine deficiency. Can J Cardiol 5 (1989) 47-50
13. Pons R., and de Vivo D.C. Primary and secondary carnitine deficiency syndromes. J Child Neurol 10 (1995) S8-S24
14. Bargen-Lockner C., Hahn P., and Wittmann B. Plasma carnitine in pregnancy. Am J Obstet Gynecol 140 (1981) 412-414
15. Grube M., Schwabedissen H.E.M., Präger D., Haney J., Möritz K.U., Meissner K., et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113 (2006) 1114-1122
16. Ganapathy M.E., Huang W., Rajan D.P., Carter A.L., Sugawara M., Iseki K., et al. Beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem 275 (2000) 1699-1707
17. Wu S.P., Shyu M.K., Liou H.H., Gau C.S., and Lin C.J. Interaction between anticonvulsants and human placental carnitine transporter. Epilepsia 45 (2004) 204-210
18. Kato Y., Sugiura M., Sugiura T., Wakayama T., Kubo Y., Kobayashi D., et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70 (2006) 829-837
19. +-coupled transport of l-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512 (2001) 273-284
20. Grube M., Schwabedissen H.M., Draber K., Präger D., Möritz K.-U., Linnemann K., et al. Expression, localization, and function of the carnitine transporter OCTN2 (SLC22A5) in human placenta. Drug Metab Dispos 33 (2005) 31-37
21. Kato Y., Sai Y., Yoshida K., Watanabe C., Hirata T., and Tsuji A. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol Pharmacol 67 (2005) 734-743
22. Watanabe C., Kato Y., Sugiura T., Kubo Y., Wakayama T., Iseki S., et al. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression. Drug Metab Dispos 34 (2006) 1927-1934
23. Kato Y., Yoshida K., Watanabe C., Sai Y., and Tsuji A. Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm Res 21 (2004) 1886-1894
24. Thiele I.G.I., Niezen-Koning K.E., van Gennip A.H., and Aarnoudse J.G. Increased plasma carnitine concentrations in preeclampsia. Obstet Gynecol 103 (2004) 876-880
25. Lee X., Keith Jr. J.C., Stumm N., Moutsatsos I., McCoy J.M., Crum C.P., et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 22 (2001) 808-812
26. Knerr I., Beinder E., and Rascher W. Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol 186 (2002) 210-213
27. Li H., Dakour J., Kaufman S., Guilbert L.J., Winkler-Lowen B., and Morrish D.W. Adrenomedullin is decreased in preeclampsia because of failed response to epidermal growth factor and impaired syncytialization. Hypertension 42 (2003) 895-900
28. Morrish D.W., Linetsky E., Bhardwaj D., Li H., Dakour J., Marsh R.G., et al. Identification by subtractive hybridization of a spectrum of novel and unexpected genes associated with in vitro differentiation of human cytotrophoblast cells. Placenta 17 (1996) 431-441
29. Aronow B.J., Richardson B.D., and Handwerger S. Microarray analysis of trophoblast differentiation: gene expression reprogramming in key gene function categories. Physiol Genomics 6 (2001) 105-116
30. Kudo Y., Boyd C.A.R., Sargent I.L., Redman C.W.G., Lee J.M., and Freeman T.C. An analysis using DNA microarray of the time course of gene expression during syncytialization of a human placental cell line (BeWo). Placenta 25 (2004) 479-488
31. Lin C.J., Chen C.H., Liu F.W., Kang J.J., Chen C.K., Lee S.L., et al. Inhibition of intestinal glucose uptake by aporphines and secoaporphines. Life Sci 79 (2006) 144-153
32. Frendo J.L., Olivier D., Cheynet V., Blond J.L., Bouton O., Vidaud M., et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23 (2003) 3566-3574
33. Rytting E., and Audus K.L. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells. J Pharmacol Exp Ther 312 (2005) 192-198
34. Pietrement C., Da Silva N., Silberstein C., James M., Marsolais M., Van Hoek A., et al. Role of NHERF1, cystic fibrosis transmembrane conductance regulator, and cAMP in the regulation of aquaporin 9. J Biol Chem 283 (2008) 2986-2996
35. Seamon K.B., Padgett W., and Daly J.W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78 (1981) 3363-3367
36. Crocker I.P., Barratt S., Kaur M., and Baker P.N. The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts. Placenta 22 (2001) 822-830
37. Tamai I., Yabuuchi H., Nezu J.-I., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419 (1997) 107-111
38. Yabuuchi H., Tamai I., Nezu J.I., Sakamoto K., Oku A., Shimane M., et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289 (1999) 768-773
39. Xuan W., Lamhonwah A.M., Librach C., Jarvi K., and Tein I. Characterization of organic cation/carnitine transporter family in human sperm. Biochem Biophys Res Commun 306 (2003) 121-128
40. Ciarimboli G., Struwe K., Arndt P., Gorboulev V., Koepsell H., Schlatter E., et al. Regulation of the human organic cation transporter hOCT1. J Cell Physiol 201 (2004) 420-428
41. Mehrens T., Lelleck S., Cetinkaya I., Knollmann M., Hohage H., Gorboulev V., et al. The affinity of the organic transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. J Am Soc Nephrol 11 (2000) 1216-1224
42. Cetinkaya I., Ciarimboli G., Yalcinkaya G., Mehrens T., Velic A., Hirsch J.R., et al. Regulation of human organic cation transporter in hOCT2 by PKA, PI3K, and calmodulin-dependent kinases. Am J Physiol Renal Physiol 284 (2003) F293-F302
43. Wu X., Prasad P.D., Leibach F.H., and Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246 (1998) 589-595
44. Rytting E., and Audus K.L. Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells. Biochem Pharmacol 75 (2008) 745-751
45. Kato Y., Watanabe C., and Tsuji A. Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors. Eur J Pharm Sci 27 (2006) 487-500
46. Gisler S.M., Stagljar I., Traebert M., Bacic D., Biber J., and Murer H. Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 276 (2001) 9206-9213
47. Wade J.B., Welling P.A., Donowitz M., Shenolikar S., and Weinman E.J. Differential renal distribution of NHERF isoforms and their colocalization with NHE3, ezrin, and ROMK. Am J Physiol 280 (2001) C192-C198
48. Donowitz M., Cha B., Zachos N.C., Brett C.L., Sharma A., Tse C.M., et al. NHERF family and NHE3 regulation. J Physiol 567 (2005) 3-11
49. Gisler S.M., Madjdpour C., Bacic D., Pribanic S., Taylor S.S., Biber J., et al. PDZK1: II. An anchoring site for the PKA-binding protein D-AKAP2 in renal proximal tubular cell. Kidney Int 64 (2003) 1746-1754
50. Lamprecht G., Weinman E.J., and Yun C.H. The role of NHERF and E3KARP in the cAMP-mediated inhibition of NHE3. J Biol Chem 273 (1998) 29972-29978
51. + exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci USA 94 (1997) 3010-3015
52. Gisler S.M., Pribanic S., Bacic D., Forrer P., Gantenbein A., Sabourin L.A., et al. PDZK1: I. A major scaffolder in brush borders of proximal tubular cells. Kidney Int 64 (2003) 1733-1745